Influence of the postnatal administration of tumor necrosis factor plus interferon-alpha 2b on the development of ethyl-nitrosourea-induced brain tumors in rats.
Using the experimental model of brain tumors induced by ethyl-nitrosourea (ENU), interferon-alpha 2b and human recombinant tumor necrosis factor-alpha (TNF) have been administered to Wistar rats between 100 and 130 days of life (one injection each week, by intraperitoneal route, of 100 micrograms of TNF and 10(4) IU of interferon-alpha 2b, in a total volume of 1 ml per injection). The results obtained suggest, that at this time, this association achieves a reduction in the number of so-called 'malignant schwannomas', but it does not influence the time of appearance nor the number of so-called 'malignant schwannomas', but it does not influence the time of appearance nor the number of so-called 'oligodendroglioma-like tumors'. On the basis of previous observations about cytokine modulation of these ENU-induced neoplasms, a different course of time for obtaining a postnatal biomodulation of both type of tumors is suggested.
Zurita
M
M
Department of Cell Biology, Faculty of Medicine, Complutensis University, Madrid, Spain.
Cabrera
M M
MM
Morales
C
C
Oya
S
S
Vaquero
J
J
D000375:Aging / Q000502:physiology; D000818:Animals; D001932:Brain Neoplasms / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D005038:Ethylnitrosourea; D005260:Female; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology*; D009442:Neurilemmoma / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D009837:Oligodendroglioma / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D005038:Ethylnitrosourea